Clinical Outcomes of People Who Acquired HIV in Early Life
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 200
Summary
- Conditions
- HIV
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Background: Antiretroviral therapy (ART) has altered the natural history of HIV disease in children. Long-term survivors of pediatric HIV infection offer a tremendous opportunity to understand the effects of HIV and ART health outcomes. A thorough understanding of the impact of HIV and ART on these ...
Background: Antiretroviral therapy (ART) has altered the natural history of HIV disease in children. Long-term survivors of pediatric HIV infection offer a tremendous opportunity to understand the effects of HIV and ART health outcomes. A thorough understanding of the impact of HIV and ART on these long-term processes is extremely relevant as ART programs for HIV-infected children expand globally. Objective: - To explore the clinical outcomes and the impact of HIV infection and ART on a cohort with HIV infection acquired in early life Eligibility: Individuals at least 18 years of age who acquired HIV infection in early life Healthy volunteers without HIV (greater than or equal to 18 years of age) will serve as controls Design: - Annual evaluations of health status, immune function and other health parameters related to HIV infection will be conducted.
Tracking Information
- NCT #
- NCT01656564
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Colleen M Hadigan, M.D. National Institute of Allergy and Infectious Diseases (NIAID)
Get Well Soon